BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Uterine cancer

1. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. NUTM2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. KAT6B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. SEPT5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. WHSC1
    [Clinical Outcome] [